contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


carnegie-access-opticept-technologies-fps-revenue-pushed-back-progress-in-cuttings-q4-review

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

OptiCept Technologies förser livsmedels-och växtindustrin med teknologiska lösningar som används för att öka hållbarheten för diverse råvaror. Bolaget arbetar med biologiska processer som ger en ökad extraktion ur råvaran, minskat avfall samt bibehållen smak, doft, färg, näringsinnehåll. Bolaget har en patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion). Bolaget säljer sina produkter på en global nivå och har sitt huvudkontor i Lund.

Har missat senaste analysen om OptiCept? Läs den här:                  Inderes              OptiCept Q3'24: Secures crucial funding for growth - Inderes    The capital raise announced on Friday reduces the financing risks and secures the company’s financing until the end of 2025. Due to the overall structure of the raise, we expect it to succeed. With short-term financing in check, OptiCept can increase...                             I helgen meddelade OptiCept om ett nytt avtal, denna gång i Thailand. Läs analytikerkommentaren här:                  Inderes              OptiCept enters agreement in Thailand - Inderes    OptiCept has announced that it has signed an agreement for its PEF technology with a global producer of pineapple products in Thailand. We view the growing recognition of OptiCept's PEF technology in Thailand as positive as the country is among the...

Jesper intervjuade analytiker Lucas om företaget och dess Q3.                    Inderes              OptiCept Q3´24: Säkerställer viktig finansiering för tillväxt - Inderes    Time: 2024-10-23 14:16 OptiCept meddelade i slutet av förra veckan att de genomför en företrädesemission och samtidigt publicerade sin Q3 rapport, tidigare än planerat. Hör analytiker Lucas tankar om det tredje kvartalet och vad kapitalanskaffningen...                             00:00 Inledning  00:19 Kortsiktiga finansieringen under kontroll  01:22 Hur lång tid kommer pengarna hålla  02:37 Intäktsnivån  03:32 Kostnadskontroll  03:52 Operationella utveckling under året  05:19 Viktigt framåt för OptiCept

OptiCept har tecknat ett hyresavtal med det centralamerikanska företaget Mexifrutas om att hyra OptiCepts PEF-system för att effektivisera extraktionen av ananasjuice. En framgångsrik utvärderingsperiod kan leda till ett långsiktigt samarbete och hjälpa till att utöka OptiCepts kommersiella skala inom frukt- och juiceindustrin. Projektet är dock i ett tidigt skede.                    Inderes              OptiCept enters rental agreement for JuiceCept in Central America - Inderes    OptiCept has announced that it has signed a rental agreement with a customer in Central America for an OptiCept PEF system to increase pineapple juice extraction. If the evaluation during the rental period is successful and a potential long-term...

OptiCept har meddelat att deras kund La Salud har fått ekonomiskt stöd från EU, vilket var en viktig förutsättning för att gå vidare med den tidigare kommunicerade beställningen av två OliveCept-system.                    Inderes              OptiCept secures previously communicated conditional order - Inderes    OptiCept has announced that its customer, La Salud, has received financial support from the European Union, which was a key condition to proceed with the previously communicated order for two OliveCept systems. This development is in line with our...

OptiCept has announced that it has entered into a Memorandum of Understanding (MoU) with Saab, a key player within the defense industry. The Mou is intended to explore the possibility of forming a long-term partnership in Thailand focused on productivity improvements for the food and forestry sectors.                   Inderes              OptiCept explores long-term partnership in Thailand - Inderes    OptiCept has announced that it has entered into a Memorandum of Understanding (MoU) with Saab, a key player within the defense industry. The Mou is intended to explore the possibility of forming a long-term partnership in Thailand focused on...

Under första halvåret har OptiCept gjort betydande framsteg mot att nå en bredare kommersialisering. OptiCept har bland annat säkrat sin första storskaliga order (60 Mkr) från sin partner FPS. Bolaget gör också framsteg med att bygga upp ett partnerskap för sin nya produkt OptiBoost Inside.                  Inderes              OptiCept Q2'24: Gearing up for larger deliveries - Inderes    During the first half of the year, OptiCept has made significant progress towards reaching broader commercialization. Among other things, OptiCept has secured its first large-scale order (60 MSEK) from its partner FPS. The company is also making...

Analytikerkommentar inför Q2 rapporten från OptiCept:                   Inderes              OptiCept Q2’24 earnings preview: Strong revenue growth expected - Inderes    OptiCept will release its Q2 results on Thursday. We expect strong revenue growth mainly due to higher deliveries within FoodTech. Profitability is expected to remain negative due to the still low absolute revenue level. In the upcoming Q2 report, we...

OptiCept Technologies

Carnegie has published a new commissioned research report on OptiCept Technologies.To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research...

<div class="mfn-preamble"><p><strong>Carnegie has published a new commissioned research report on OptiCept Technologies.</strong></p></div><div class="mfn-body"><p>To access the full report and subscribe to future updates, visit <a rel="noopener" href="https://www.carnegie.se/en/commissioned-research/opticept/">https://www.carnegie.se/en/commissioned-research/opticept/</a></p></div><div class="mfn-footer mfn-6fcd5977fc3f"><p><strong class="mfn-heading-1">Information</strong><br>This is a press release from Carnegie. For information about Carnegie commissioned research, see <a rel="noopener" href="https://www.carnegie.se/en/commissioned-research/">https://www.carnegie.se/en/commissioned-research/</a>, or contact our commissioned research team at <a rel="noopener" href="mailto:cr@carnegie.se">cr@carnegie.se</a>.</p></div><div class="mfn-footer mfn-contacts mfn-cb03f74a6f11"><p><strong class="mfn-heading-1">Contacts</strong><br>Visiting&nbsp;address: Regeringsgatan 56, Stockholm<br>Site: <a rel="noopener" href="http://www.carnegie.se/">http://www.carnegie.se</a><br>Telephone: +46 8-5886 88 00</p></div><div class="mfn-footer mfn-about mfn-f597257b14ff"><p><strong class="mfn-heading-1">About Us</strong><br>Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. Carnegie operates in six countries and has more than 800 employees.</p></div>

Carnegie Access: OptiCept Technologies: FPS revenue pushed back, progress in cuttings – Q4 review

Sekretessinställningar